MCM
MED icon

MAI Capital Management’s Medifast MED Stock Holding History

MAI Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-57
Closed -$581 – 3643
2026
Q1 		$581 Buy
57
+47
+470% +$507 ﹤0.01% 4365
2025
Q4 		$107 Buy
+10
New +$120 ﹤0.01% 4158
2025
Q2 		– Sell
-61
Closed -$826 – 4015
2025
Q1 		$826 Buy
+61
New +$916 ﹤0.01% 3172

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MAI Capital Management's MED Position: Q2 2026 in Review

MAI Capital Management sold out of Medifast (MED) in Q2 2026, closing a stake of 57 shares — an estimated $581 sold.

MAI Capital Management first reported a position in MED in Q1 2025 and held it in 3 quarters. The position peaked at $826 in Q1 2025. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • MAI Capital Management reported no remaining Medifast position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 57 Medifast shares in Q2 2026, an estimated $581.
  • MAI Capital Management first reported a position in Medifast in Q1 2025 and held it in 3 quarters.
  • MAI Capital Management's Medifast position peaked at $826 in Q1 2025.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.